Biomarkers of Alzheimer's disease pathophysiology and delirium

Key Points

• The study aims to identify biomarkers associated with Alzheimer’s disease and delirium in order to understand their pathophysiology.
• Analyzed clinical samples from health authorities and associations in Norway.
• Evaluated different biomarkers in relation to Alzheimer’s disease and delirium.
• Utilized funding from Wellcome Leap's Dynamic Resilience Program.
• Identified several key biomarkers that correlate with Alzheimer’s disease.
• Noted potential links between these biomarkers and the occurrence of delirium.